>
Inside the Fight ff MI6 and CIA Proxies Over Who Is To Lead Ukraine
The Real Elites vs. The Ruling Elites
The State Spins a New Idea for Recruiting in an Age of War
Woke Nike Booted from S&P 100 as Stock Crashes on Dismal Sales
Floating data center would provide water and electricity to 32,000 homes
OpenAI Cuts Off Elon's Cursor, Humanity's First Star Probe, and Trump's Nuclear Mars Shi
Eating pollution? Plastic-to-cookie technology raises safety, environmental concerns
Ford's $30,000 Fathom EV Truck Appears More Conventional Than Expected
Berlin-based artist Simon Weckert explored that idea with Digital Camouflage...
Tether expands tokenization business into Saudi Arabia, starting with real estate
Ukraine is facing a new problem in its war with Russia:
It charges more than it discharges while driving

Dr. Aubrey de Grey of SENS Research Foundation gave the keynote speech at Ending Age-Related Diseases 2020. Aubrey discussed the current state of the rejuvenation biotechnology industry and how the current pandemic is shifting medical and science priorities. He mentions the failure of Unity Biotechnology's Phase 2 clinical trial for osteoarthritis, COVID-19 and the elderly immune system, the current popularization of rejuvenation biotechnology and developments to a world without age-related diseases.
There is now funding for the detailed work to define an Aging reversal XPrize focused on rejuvenating the immune system. The detailed definition of an XPrize requires nearly $1 million. Michael Antonov and Sergey Young have provided the funding.